Clinical Trials
4 trialsNCT00419328 2022-07-21
A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors
AGC Biologics S.p.A.
Phase 1 Completed
NCT00305084 2019-10-04
Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
AGC Biologics S.p.A.
Phase 1 Completed
NCT00878111 2018-08-29
Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour
AGC Biologics S.p.A.
Phase 1 Completed
NCT00483093 2014-05-30
Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor
AGC Biologics S.p.A.
Phase 1 Completed